Mok TSK, Lopes G, Cho BC, Kowalski DM, et al. Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC. Ann Oncol 2023;34:377-388.
PMID: 36709038